PRONALIX

This brand name is authorized in Nigeria.

Active ingredients

The drug PRONALIX contains one active pharmaceutical ingredient (API):

1	Indapamide UNII F089I0511L - INDAPAMIDE
	Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action.
	Read more about Indapamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100731	Tablet	PRONALIX SR 1.5MG TABLET TAB 1.5 mg 3x10	27 NF-PP-354436 PRONALIX SR 1.5MG TABLET Indapamide Sustained Release tablet Indapamide (Active Ingredient) Excipients 1. Ready to use sustained release 2. Opashite white 3. IPA 4. Polyethylene Glycol (PEG) 6000 A4-100731 Drugs Imported Products 310 Prescription Only Medicine (POM) 9/1/2023 PROVAMATI HEALTHCARE COMPANY LIMITED, 2 Ayodele Fanoiki Way, Magodo, Lagos Nigeria 7030857451 regulatory@provamati.com Don Valley Pharmaceuticals Pvt. Ltd., 31-KM Main Ferozpur Road Lahore-Pakistan., Pakistan	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03BA11	Indapamide	C Cardiovascular system → C03 Diuretics → C03B Low-ceiling diuretics, excl. thiazides → C03BA Sulfonamides, plain
Discover more medicines within C03BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100731